1822-51-1Relevant articles and documents
A 4 - chloromethyl pyridine hydrochloride synthetic method
-
, (2019/06/05)
The invention belongs to the field of organic synthesis, in particular to a 4 - chloromethyl pyridine hydrochloride synthetic method, the method comprises the following steps: (1) to 4 - methyl pyridine as raw materials, takes water as a solvent, the potassium permanganate oxide it to 4 - pyridine carboxylic acid, wherein 4 - methyl pyridine with potassium permanganate in a molar ratio of 1: 2.1 - 2.3, the oxidation temperature is 75 - 80 °C, heating 35 min, the reaction is complete the reaction liquid is adjusted to be acidic, and then cooling and filtering to obtain 4 - pyridine carboxylic acid; (2) 4 - pyridine carboxylic acid with methanol under acidic conditions to produce the 4 - pyridine carboxylic acid methyl ester, wherein the 4 - pyridine carboxylic acid with methanol in a molar ratio of 1: 1.3; (3) reduction of 4 - pyridine carboxylic acid methyl ester for 4 - pyridine methanol; (4) 4 - pyridine methanol with thionyl chloride reaction to obtain the target product 4 - chloromethyl pyridine hydrochloride, 4 - pyridine methanol with thionyl chloride in a molar ratio of 1: 1.1 - 1.3.
Facile and Selective Synthesis of Chloromethylpyridines and Chloropyridines Using Diphosgene/Triphosgene
Narendar,Gangadasu,Ramesh, Ch.,Raju, B. China,Rao, V. Jayathirtha
, p. 1097 - 1103 (2007/10/03)
Diphosgene and triphosgene in the presence of amines were found to be an excellent chlorinating agents with high selectivity for the preparation of chloromethylpyridines and chloropyridines from picoline-N-oxides and pyridine-N-oxides respectively.
Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
-
, (2008/06/13)
Compounds, pharmaceutical compositions, and methods for the treatment of a hyperlipidemic condition in a subject. The compounds of the present invention are apical sodium co-dependent bile acid transport inhibitors and are 1,4-benzothiazepine and 1,5-benzothiazepine compounds corresponding to Formula I: wherein j, m, Y, Z, R1A, R1B, R2A, R2B and R6 are as defined in the specification.